November 30, 2022
Research reveals how a potentially fatal COVID-19 complication damages lung tissueMechanisms involved in the rapid, severe progression of fibrosis in the lung tissues of COVID-19 patients, a potentially fatal complication of the virus that damages and scars the lungs, have been uncovered by researchers led by UTHealth Houston.
October 7, 2022
UTHealth Houston study finds pediatric firearm injuries increased during the COVID-19 pandemicResearchers at UTHealth Houston saw an increase in pediatric firearm-related injuries during the COVID-19 pandemic, despite also seeing a decrease in total pediatric emergency department (ED) visits over the same period, according to a poster presented at the 2022 American Academy of Pediatrics National Conference & Exhibition in Anaheim, California.
October 4, 2022
Method for detecting waves of COVID-19 infections can shape critical public health decisions during a pandemicA method that combines case investigation data from local health departments and hospitalizations records from local institutions allows for the objective detection of new waves of infection during a pandemic, according to research from UTHealth Houston.
September 29, 2022
Among people with obesity, nearly 30% gained significant weight during the COVID-19 pandemic due to mental health factorsStress, anxiety, depression, and lack of sleep contributed to weight gain over the COVID-19 pandemic for people with obesity, according to researchers at UTHealth Houston and UT Southwestern Medical Center.
September 22, 2022
Tao receives grant to construct vaccine knowledge baseA four-year, $1.2 million grant that will help create a vaccine knowledge base has been given to researchers at UTHealth Houston, which is a subcontractor on a larger, $3.7 million grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID).
September 8, 2022
UTHealth Houston OMS treats COVID associated avascular necrosis of the maxillaFor the better part of two years, 72-year-old William Baker’s health journey has been an uphill climb. With a COVID-associated avascular necrosis of the maxilla, he was referred to James C. Melville, DDS, and UTHealth Houston Oral and Maxillofacial Surgeons to treat his rare side effect.
August 8, 2022
Children infected with a mild case of COVID-19 can still develop long COVID symptomsWhile research has revealed that children and adults hospitalized with COVID-19 are more susceptible to developing long COVID symptoms, a new study by researchers at UTHealth Houston found that children infected with COVID-19, but not hospitalized, still experienced long COVID symptoms up to three months past infection.
The study was published in The Pediatric Infectious Disease Journal.
July 20, 2022
Anti-inflammatory compound shows potential in treating patients with severe COVID-19An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chances of death, according to a new study from UTHealth Houston and other institutions.
July 15, 2022
Inpatient Otolaryngology Consults in the COVID-19 EraDuring consultations with head and neck surgeons, a significantly higher proportion of patients who tested positive for COVID-19 were treated for nosebleeds compared to patients who tested negative for the virus, according to researchers at UTHealth Houston.
June 28, 2022
Awake prone positioning does not offer benefit in reducing intubation for COVID-19 induced acute respiratory failureA large multicenter, randomized clinical trial revealed no difference in the risk of endotracheal intubation requirement at 30 days between awake prone positioning and standard positioning for patients with COVID-19 who suffered from acute hypoxemic respiratory failure, according to research published in JAMA by researchers at UTHealth Houston.
May 31, 2022
COVID-19 antibodies can last up to 500 days after infectionAdults infected with COVID-19 develop circulating antibodies that last for nearly 500 days, according to a new study led by researchers at UTHealth School of Public Health.
The findings were published in The Journal of Infectious Diseases.
May 11, 2022
School of Biomedical Informatics researchers develop AI-based COVID-19 predictive modelsA team of researchers from UTHealth Houston created an artificial intelligence model to predict which COVID-19 patients might be more at risk for severe illness, according to an article that was published recently in the Lancet Digital Health.
March 18, 2022
Natural COVID-19 antibodies lasts seven months for children, according to new studyChildren previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at UTHealth Houston.
January 31, 2022
HRSA grants $10.3 million to increase COVID-19 vaccination rates for three minority, low-income populations in TexasA one-year, $10.3 million dollar grant from the U.S. Health Resources and Services Administration (HRSA) was awarded to increase COVID-19 vaccinations through the development and mobilization of existing community-based health and outreach workforces in the state by The University of Texas Health Science Center at Houston (UTHealth Houston).
June 3, 2021
Preclinical research reveals that new IgM antibodies administered intranasally to fight COVID-19 more potent than commonly used onesA nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc.
August 21, 2020
Grant launches research into COVID-19 symptoms among cancer patientsAn interprofessional team is studying COVID-19 symptoms among people with and without cancer through new grant awarded to Cizik School of Nursing at UTHealth Assistant Professor Meagan Whisenant, PhD, APRN. Faculty from across the UTHealth campus and The University of Texas MD Anderson Cancer Center are participating in the research project.